Fairfield Financial Advisors LTD Has $1.10 Million Stock Position in Danaher Co. (NYSE:DHR)

Fairfield Financial Advisors LTD lowered its holdings in shares of Danaher Co. (NYSE:DHR) by 28.7% in the 3rd quarter, HoldingsChannel reports. The firm owned 3,951 shares of the conglomerate’s stock after selling 1,587 shares during the period. Fairfield Financial Advisors LTD’s holdings in Danaher were worth $1,099,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. CarsonAllaria Wealth Management Ltd. acquired a new stake in Danaher during the second quarter worth approximately $25,000. nVerses Capital LLC acquired a new stake in Danaher during the second quarter worth approximately $25,000. MFA Wealth Advisors LLC acquired a new stake in Danaher during the second quarter worth approximately $51,000. Financial Connections Group Inc. acquired a new stake in Danaher during the second quarter worth approximately $51,000. Finally, Western Pacific Wealth Management LP acquired a new stake in Danaher during the first quarter worth approximately $55,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

DHR has been the subject of a number of research reports. Stifel Nicolaus raised their price objective on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. UBS Group reduced their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Barclays reduced their price objective on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 23rd. TD Cowen raised their price objective on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Finally, The Goldman Sachs Group raised their price objective on Danaher from $225.00 to $250.00 and gave the company a “neutral” rating in a research note on Wednesday, July 24th. Six investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

Danaher Stock Performance

Danaher stock traded up $4.07 during mid-day trading on Thursday, reaching $246.39. 1,719,518 shares of the company’s stock were exchanged, compared to its average volume of 2,737,755. The business’s fifty day simple moving average is $267.83 and its 200 day simple moving average is $260.42. The firm has a market capitalization of $182.50 billion, a PE ratio of 41.07, a P/E/G ratio of 4.49 and a beta of 0.83. Danaher Co. has a one year low of $188.75 and a one year high of $281.70. The company has a quick ratio of 1.04, a current ratio of 1.43 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 11.06% and a net margin of 16.94%. Danaher’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period last year, the company posted $2.02 earnings per share. On average, sell-side analysts expect that Danaher Co. will post 7.59 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. Danaher’s payout ratio is presently 18.31%.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the sale, the senior vice president now directly owns 4,212 shares in the company, valued at $1,130,374.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.